These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25552671)

  • 1. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: rarely a good value.
    Majithia A; Reynolds MR
    Europace; 2015 Jan; 17(1):5-6. PubMed ID: 25552671
    [No Abstract]   [Full Text] [Related]  

  • 2. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
    Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
    Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation of atrial fibrillation: is the burn worth the buck?
    Estes NA
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):914-6. PubMed ID: 17666055
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost comparison of catheter ablation and medical therapy in atrial fibrillation.
    Khaykin Y; Morillo CA; Skanes AC; McCracken A; Humphries K; Kerr CR
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):907-13. PubMed ID: 17666065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lone atrial fibrillation--relevance for medical underwriting].
    Filzmaier K
    Versicherungsmedizin; 2013 Sep; 65(3):128-31. PubMed ID: 24137892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.
    Khaykin Y; Wang X; Natale A; Wazni OM; Skanes AC; Humphries KH; Kerr CR; Verma A; Morillo CA
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):7-12. PubMed ID: 18803564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.
    Nault I; Miyazaki S; Forclaz A; Wright M; Jadidi A; Jaïs P; Hocini M; Haïssaguerre M
    Eur Heart J; 2010 May; 31(9):1046-54. PubMed ID: 20332181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
    Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
    J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of atrial fibrillation catheter ablation.
    Andrikopoulos G; Tzeis S; Maniadakis N; Mavrakis HE; Vardas PE
    Europace; 2009 Feb; 11(2):147-51. PubMed ID: 19098290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of catheter ablation for paroxysmal atrial fibrillation.
    Weerasooriya R; Jaïs P; Le Heuzey JY; Scaveé C; Choi KJ; Macle L; Raybaud F; Hocini M; Shah DC; Lavergne T; Clémenty J; Haïssaguerre M
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):292-4. PubMed ID: 12687831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United States.
    Kim MH; Lin J; Kreilick C; Foltz Boklage SH
    Adv Ther; 2010 Sep; 27(9):600-12. PubMed ID: 20700678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of atrial fibrillation: invasive vs non-invasive management in 2012.
    Khaykin Y; Shamiss Y
    Curr Cardiol Rev; 2012 Nov; 8(4):368-73. PubMed ID: 22920478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: pro.
    Santangeli P; Di Biase L; Natale A
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):739-46. PubMed ID: 25140019
    [No Abstract]   [Full Text] [Related]  

  • 14. Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: con.
    Hanley CM; Esberg D; Kowey PR
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):747-54. PubMed ID: 25140020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cost-benefit analysis of concomitant atrial fibrillation management in Spain].
    López Gude MJ; Rodríguez Bezos D; Rodríguez Barrios JM
    Gac Sanit; 2010; 24(1):59-65. PubMed ID: 19931216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact to employers of treatment options for cardiac arrhythmias in the US health system.
    Kleinman NL; Rohrbacker NJ; White SA; March JL; Reynolds MR
    J Occup Environ Med; 2011 Apr; 53(4):405-14. PubMed ID: 21407098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
    Chimienti M; Barbieri S
    G Ital Cardiol; 1996 Feb; 26(2):213-26. PubMed ID: 8666179
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations.
    Neyt M; Van Brabandt H; Devos C
    BMC Cardiovasc Disord; 2013 Sep; 13():78. PubMed ID: 24070126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Cost-effectiveness of rate control vs. rhythm control for patients with atrial fibrillation.
    Ann Intern Med; 2004 Nov; 141(9):I20. PubMed ID: 15520416
    [No Abstract]   [Full Text] [Related]  

  • 20. Catheter ablation as first-line therapy for patients with symptomatic atrial fibrillation.
    Chugh A
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):663-72. PubMed ID: 17605645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.